Literature DB >> 32052185

Clinicopathological and molecular correlations in traditional serrated adenoma.

Shigeki Sekine1,2, Satoshi Yamashita3, Masayoshi Yamada4, Taiki Hashimoto5, Reiko Ogawa6, Hiroshi Yoshida5, Hirokazu Taniguchi5, Motohiro Kojima7, Toshikazu Ushijima3, Yutaka Saito4.   

Abstract

BACKGROUND: Traditional serrated adenoma (TSA) is the least common type of colorectal serrated polyp, which exhibits considerable morphological and molecular diversity.
METHODS: We examined the spectra of alterations in MAPK and WNT pathway genes and their relationship with clinicopathological features in 128 TSAs.
RESULTS: Sequencing analyses identified BRAF V600EBRAF non-V600EKRAS, and NRAS mutations in 77, 3, 45, and 1 lesion, respectively. Collectively, 124 lesions (97%) had mutations in MAPK pathway genes. Alterations in WNT pathway genes were identified in 107 lesions (84%), including RSPO fusions/overexpression, RNF43 mutations, ZNRF3 mutations, APC mutations, and CTNNB1 mutations in 47, 45, 2, 13, and 2 lesions, respectively. Ten lesions (8%) harbored GNAS mutations. There was significant interdependence between the altered MAPK and WNT pathway genes. RSPO fusions/overexpression was significantly associated with KRAS mutations (31/47, 66%), whereas most RNF43 mutations coexisted with the BRAF V600E mutation (40/45, 89%). Histologically, extensive slit-like serration was more common in lesions with the BRAF V600E mutation (71%) and those with RNF43 mutations (87%). Prominent ectopic crypt formation was more prevalent in lesions with RSPO fusions/overexpression (58%) and those with GNAS mutations (100%).
CONCLUSIONS: Our observations indicate that TSAs mostly harbor various combinations of concurrent WNT and MAPK gene alterations. The associations between genetic and morphological features suggest that the histological diversity of TSA reflects the underlying molecular heterogeneity.

Entities:  

Keywords:  MAPK pathway; Traditional serrated adenoma; WNT pathway

Year:  2020        PMID: 32052185     DOI: 10.1007/s00535-020-01673-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  34 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.

Authors:  Shigeki Sekine; Satoshi Yamashita; Taro Tanabe; Taiki Hashimoto; Hiroshi Yoshida; Hirokazu Taniguchi; Motohiro Kojima; Kazuya Shinmura; Yutaka Saito; Nobuyoshi Hiraoka; Toshikazu Ushijima; Atsushi Ochiai
Journal:  J Pathol       Date:  2016-04-09       Impact factor: 7.996

3.  Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.

Authors:  Homer O Wiland; Bonnie Shadrach; Daniela Allende; Paula Carver; John R Goldblum; Xiuli Liu; Deepa T Patil; Lisa A Rybicki; Rish K Pai
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

4.  The role of APC in WNT pathway activation in serrated neoplasia.

Authors:  Jennifer Borowsky; Troy Dumenil; Mark Bettington; Sally-Ann Pearson; Catherine Bond; Lochlan Fennell; Cheng Liu; Diane McKeone; Christophe Rosty; Ian Brown; Neal Walker; Barbara Leggett; Vicki Whitehall
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

5.  Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.

Authors:  Jia-Huei Tsai; Jau-Yu Liau; Yu-Lin Lin; Liang-In Lin; Yi-Chen Cheng; Mei-Ling Cheng; Yung-Ming Jeng
Journal:  Mod Pathol       Date:  2014-03-07       Impact factor: 7.842

6.  Mucin-rich variant of traditional serrated adenoma: a distinct morphological variant.

Authors:  Sangeetha N Kalimuthu; Stefano Serra; Sara Hafezi-Bakhtiari; Richard Colling; Lai Mun Wang; Runjan Chetty
Journal:  Histopathology       Date:  2017-05-05       Impact factor: 5.087

7.  Serrated lesions of the colorectum: review and recommendations from an expert panel.

Authors:  Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

8.  High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.

Authors:  Kevin J Spring; Zhen Zhen Zhao; Rozemary Karamatic; Michael D Walsh; Vicki L J Whitehall; Tanya Pike; Lisa A Simms; Joanne Young; Michael James; Grant W Montgomery; Mark Appleyard; David Hewett; Kazutomo Togashi; Jeremy R Jass; Barbara A Leggett
Journal:  Gastroenterology       Date:  2006-08-18       Impact factor: 22.682

9.  Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.

Authors:  Michael J O'Brien; Shi Yang; Charline Mack; Huihong Xu; Christopher S Huang; Elizabeth Mulcahy; Mark Amorosino; Francis A Farraye
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

10.  Immunohistochemical and genetic characteristics of a colorectal mucin-rich variant of traditional serrated adenoma.

Authors:  Takafumi Hiromoto; Takashi Murakami; Yoichi Akazawa; Noriko Sasahara; Tsuyoshi Saito; Naoto Sakamoto; Hiroyuki Mitomi; Akihito Nagahara; Takashi Yao
Journal:  Histopathology       Date:  2018-06-22       Impact factor: 5.087

View more
  5 in total

1.  Serrated adenomas with a BRAF mutation in a young patient with familial adenomatous polyposis.

Authors:  Kentaro Moriichi; Hiroki Tanabe; Yusuke Ono; Yu Kobayashi; Yuki Murakami; Takuya Iwama; Takehito Kunogi; Takahiro Sasaki; Keitaro Takahashi; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Hidehiro Takei; Yusuke Mizukami; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Int J Colorectal Dis       Date:  2020-06-05       Impact factor: 2.571

2.  Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.

Authors:  Taiki Hashimoto; Daisuke Takayanagi; Junpei Yonemaru; Tomoaki Naka; Kengo Nagashima; Yasushi Yatabe; Dai Shida; Ryuji Hamamoto; Sam O Kleeman; Simon J Leedham; Timothy Maughan; Atsuo Takashima; Kouya Shiraishi; Shigeki Sekine
Journal:  Br J Cancer       Date:  2022-06-17       Impact factor: 9.075

3.  BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation.

Authors:  Nadine Reischmann; Geoffroy Andrieux; Ricarda Griffin; Thomas Reinheckel; Melanie Boerries; Tilman Brummer
Journal:  Oncogene       Date:  2020-08-13       Impact factor: 9.867

4.  Traditional serrated adenoma has two distinct genetic pathways for molecular tumorigenesis with potential neoplastic progression.

Authors:  Yoshihito Tanaka; Makoto Eizuka; Noriyuki Uesugi; Keisuke Kawasaki; Hiroo Yamano; Hiromu Suzuki; Takayuki Matsumoto; Tamotsu Sugai
Journal:  J Gastroenterol       Date:  2020-06-13       Impact factor: 7.527

5.  RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.

Authors:  Yasmijn J van Herwaarden; Lieke M Koggel; Femke Simmer; Elisa M Vink-Börger; Polat Dura; Gerrit A Meijer; Fokko M Nagengast; Nicoline Hoogerbrugge; Tanya M Bisseling; Iris D Nagtegaal
Journal:  Histopathology       Date:  2020-12-25       Impact factor: 5.087

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.